Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
Subscribe To Our Newsletter & Stay Updated